Skip to main content

From lab to launch: AI’s impact on pharma drug development

Published Date
Author Eli Daccach

Pharma and life sciences executives worldwide are generally optimistic about the pharmaceutical industry’s prospects through the end of 2025, with 68% saying they anticipate a revenue boost, in a survey by Deloitte U.S. Center for Health Solutions. Nevertheless, the industry faces some challenges around regulatory...

The post From lab to launch: AI’s impact on pharma drug development appeared first on Schneider Electric Blog.